Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations | Communications Biology
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Corbevax gets DCGI nod as heterologous Covid booster dose for adults | Mint
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above - Express Pharma
Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001 - Valneva
Frontiers | The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China
Table 5: Number of studies evaluating VE of heterologous booster schedules
DCGI approves Biological E's COVID-19 vaccine Corbevax as heterologous booster dose | Zee Business
Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination | Signal Transduction and Targeted Therapy
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant | Signal Transduction and Targeted Therapy
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study - The Lancet Global Health
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries - ScienceDirect
What is a heterologous booster vaccine? | The Hindu - YouTube
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans | NEJM
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people - The Lancet Infectious Diseases
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
What is a COVID-19 Heterologous Booster? | What is a #COVID19 Heterologous Booster? Also called a “mix and match” #booster dose, the CDC is allowing eligible individuals to choose which COVID-19...
Explained | What is a heterologous booster vaccine, and what are its advantages? - The Hindu
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
